Formulation and Optimization of Trandolapril Oro-dispersible Tablets using the Quality by Design (QbD) Approach

被引:1
|
作者
Kumar, Ganesh [1 ]
Bhatt, Meenakshi [2 ]
机构
[1] Coll Pharm, Shivalik Campus, Dehra Dun, Uttrakhand, India
[2] SGRR Univ, Sch Pharmaceut Sci, Dehra Dun, Uttrakhand, India
关键词
Oro-dispersible tablet; crospovidone; microcrystalline cellulose; quality by design; disintegration; friability; PRODUCTS;
D O I
10.2174/1570180819666220429153102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction This study aims to use a Quality by Design (QbD) approach to formulate and optimize Trandolapriloro-dispersible tablets. The central composite design tool was utilized to assess the scientific understanding of independent input variables and output responses to construct a design space for regulatory flexibility. Oro-dispersible Tablets (ODT) can also be used to deliver drugs directly to the oral mucosa, bypassing first-pass hepatic metabolism and potentially accelerating the process. Methodology The concentrations of super disintegrant and dry compressible binder were selected as independent variables. Disintegration time in seconds and % friability was selected as dependent variables. Polynomial equations were used to predict the quantitative effect of independent variables at various levels on response variables. Results and Discussion The pre-compression parameters suggested that the flow characteristics were quite excellent. All tablets prepared in the above experiments were evaluated for pharmaco-technical properties and found to be within the required limits using the direct compression method. The angle of repose of the dry blends from each formulation batch (F1 to F9) ranged from 29.03 & DEG; to 33.67 & DEG;. All formulation batches had a loose bulk density of 0.31 & PLUSMN; 0.07 to 0.37 & PLUSMN; 0.91 g/cm(3) and a tapped density of 0.41 & PLUSMN; 0.02 to 0.46 & PLUSMN; 0.16 g/cm(3), respectively. The compressibility index was determined to be between 1.65 & PLUSMN; 0.17 to 19.93 & PLUSMN; 0.47 . Hausner's ratio was between 1.14 & PLUSMN; 0.88 to 1.19 & PLUSMN; 0.32. The thickness of the tablets ranged from 2.07 & PLUSMN; 0.54 to 2.52 & PLUSMN; 0.12 mm. The tablets were found to have a hardness of 3.08 & PLUSMN; 0.14 to 3.67 & PLUSMN; 0.41 kg/cm(2). The weight of the tablets prepared ranged from 50 & PLUSMN; 0.09 to 52 & PLUSMN; 0.56 mg on average. Tablet friability was 0.52 & PLUSMN; 0.54 to 0.83 & PLUSMN; 0.10%, and the disintegration time ranged between 27 and 58 seconds. All of these parameters were found under the acceptable limit of pharmacopoeias. The increase of Crospovidone concentration decreased the disintegration time and increased % friability. Whereas increasing the concentration of microcrystalline cellulose increased the disintegration time and decreased the % friability. Contour plots clarified the link between independent and dependent variables. The most cost-effective batch was chosen based on these plots within the desired range because the actual and projected values suggested by the full model were very close to each other; the statistical model is mathematically valid. Conclusion The results showed that the proposed design for developing trandolapriloro-dispersible tablets with optimal properties was effective.
引用
收藏
页码:1194 / 1203
页数:10
相关论文
共 50 条
  • [1] FORMULATION AND EVALUATION OF METFORMIN ORO-DISPERSIBLE TABLETS
    Kamboj, Munish
    Goyal, Surinder
    Rakha, Pankaj
    Arora, Gitika
    Dureja, Harish
    Nagpal, Manju
    ACTA POLONIAE PHARMACEUTICA, 2011, 68 (05): : 717 - 723
  • [2] Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
    Almotairi, Nawaf
    Mahrous, Gamal M.
    Al-suwayeh, Saleh
    Kazi, Mohsin
    PHARMACEUTICALS, 2022, 15 (12)
  • [3] Formulation of taste masked oro-dispersible tablets of ambroxol hydrochloride
    Venkatesh, D. P.
    Rao, C. G. Geetha
    ASIAN JOURNAL OF PHARMACEUTICS, 2008, 2 (04) : 261 - 264
  • [4] FORMULATION AND EVALUATION OF MICROSPHERES BASED ORO-DISPERSIBLE ROXITHROMYCIN TABLETS USING CENTRAL COMPOSITE DESIGN
    Reena
    Dahiya, Mandeep
    Kumar, Vinesh
    Dureja, Harish
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (11): : 4651 - 4658
  • [5] FORMULATION AND IN-VITRO EVALUATION OF ZOLMITRIPTAN ORO-DISPERSIBLE TABLETS
    Bharathi, Arigela
    Ramakrishna, Vemugunta
    Anupama, Baratam
    Manisha, Chukkapalli
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 2 (06): : 988 - 995
  • [6] FORMULATION AND EVALUATION OF ORO-DISPERSIBLE TABLETS OF LORATADINE USING DIRECT COMPRESSION AND SUBLIMATION METHODS
    Karthik
    Kanagala, Pallavi
    Shaik, Naseeb Basha
    Namratha, Khoday
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 194 - 202
  • [7] Formulation and Evaluation of Oro-dispersible Bromhexine Hydrochloride Granules Using Sachelac-80
    Ayre, Anita P.
    Gajbhiye, Shilpa A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 13 (01) : 155 - 161
  • [8] Quality by design approach for formulation development: A case study of dispersible tablets
    Charoo, Naseem A.
    Shamsher, Areeg A. A.
    Zidan, Ahmed S.
    Rahman, Ziyaur
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) : 167 - 178
  • [9] FORMULATION AND IN VITRO EVALUATION OF ORO DISPERSIBLE TABLETS OF LORAZEPAM
    Anusha, Bommana
    Karike, Girija
    Maheshwari, Koppula
    Sura, Ramya Sri
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (05): : 3945 - 3953
  • [10] Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
    Alejandro, Blasco
    Guillermo, Torrado
    Angeles, Pena M.
    PHARMACEUTICALS, 2020, 13 (05)